Overview Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer Status: Recruiting Trial end date: 2024-11-30 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of Qizhu Yuling prescription for postoperative esophagus cancer. Phase: N/A Details Lead Sponsor: Jie Li